ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2043

Feasibility and Accuracy of Translating a Patient Safety Quality Measure into an Automated e-Measure

Chris Tonner1, Gabriela Schmajuk2, Laura Trupin3 and Jinoos Yazdany3, 1Rheumatology, University of California, San Francisco, San Francisco, CA, 2San Francisco VA Medical Center, University of California, San Francisco, San Francisco, CA, 3Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Electronic Health Record, Quality Indicators and quality measures

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Quality Measures and Quality of Care I

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Physician payments in the U.S. are shifting from fee-for-service to a value-based system, which will require quality measures to be extracted automatically from the electronic health record (EHR). However, the feasibility and accuracy of such “e-specification” of quality measures has not been widely reported. In this study, we compared the accuracy of automated electronic vs. manual chart review abstraction for a sample patient safety quality measure.

Methods:  We developed electronic specifications for the following measure – “If a patient receives rituximab, then s/he should be screened for prior Hepatitis B infection with Hepatitis B surface antigen and Hepatitis B core antibody tests prior to rituximab initiation, because Hepatitis B reactivation is a potentially fatal (and preventable) adverse event in this population.”  We used EHR data derived from a tertiary care university center that has almost one million outpatient visits per year. Patients were included if they had at least 2 encounters during the 12 months before and at least one encounter 30 days after their first rituximab dose during the study period (June 2012-January 2016).  We queried EHR structured data to define a denominator population of rituximab users and to classify the receipt of adequate Hepatitis B screening at any time prior to starting rituximab treatment.  Two physicians performed chart reviews, including reviewing all clinical notes and scanned documents, to validate these data.

Results:  The EHR query of structured data identified 1,167 users of rituximab in the denominator for this measure. Physician chart review found that this was an overestimate (321 patients did not receive the medication or had a historical reference to the medication). The automated query identified 618 (out of 1,167) patients in the numerator for this measure. Physician chart review found that this was an underestimate of actual testing, as 11% of the 926 patients in the denominator had additional lab results described in clinical narratives. The use of chart review in addition to electronic queries of EHR data increased the performance on this patient safety measure from 53% to 61%, representing a 15% increase.

Conclusion:  Relying solely on the extraction of structured data from the EHR resulted in an overestimate of the denominator population and an underestimate of the numerator of Hepatitis B screening for this patient safety quality measure. Such misclassifications may threaten the validity of e-measurement and potentially undermine physicians’ incentives to participate in a value-based payment system. As the number of e-Measures expands, accurate reporting will need to rely on additional strategies, including natural language processing for extraction of unstructured data from clinical notes, as well as changes to provider workflows to collect critical data elements in structured fields.


Disclosure: C. Tonner, None; G. Schmajuk, None; L. Trupin, None; J. Yazdany, None.

To cite this abstract in AMA style:

Tonner C, Schmajuk G, Trupin L, Yazdany J. Feasibility and Accuracy of Translating a Patient Safety Quality Measure into an Automated e-Measure [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/feasibility-and-accuracy-of-translating-a-patient-safety-quality-measure-into-an-automated-e-measure/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/feasibility-and-accuracy-of-translating-a-patient-safety-quality-measure-into-an-automated-e-measure/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology